Concentric Analgesics
PrivateLast Round
Convertible Debt
Jan 26, 2022
Total Funding Raised
$113.4M
Company Overview
Concentric Analgesics is a biopharmaceutical company that develops and commercializes non-opioid therapeutics for the management of postoperative and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concentric Analgesics Comparables
Compare Concentric Analgesics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allay Therapeutics | 88% | |
| Neumentum, Inc. | 87% | |
| AlgavitaBio, Inc. | 86% |
Concentric Analgesics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jan 26, 2022 | ||||
| Series B | May 21, 2019 | ||||
| Series A | Dec 1, 2016 |
Key People
Founding team and executive leadership
Concentric Analgesics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TD Securities | Series B |
| Blue Owl Capital | Series B |
| Kern Whelan Capital | Series B |
| Oracle Investment Management | Series B |
| Venrock | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 117% MoM.
- Jan 26, 2022
Raised $20M in convertible debt.
Concentric Analgesics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Concentric Analgesics's valuation, stock price, and market status.
Is Concentric Analgesic a public or private company?
Concentric Analgesic is a private company.
What is the current stock price of Concentric Analgesic?
Concentric Analgesic is a private company with no public stock price. No recent secondary market data is available.
How much is Concentric Analgesic worth (valuation)?
Valuation information for Concentric Analgesic is not publicly available.
Can I buy Concentric Analgesic stock?
Concentric Analgesic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Concentric Analgesic's last funding round?
Concentric Analgesic's most recent funding round was Convertible Debt on January 26, 2022.
Who are the main investors in Concentric Analgesic?
Key investors in Concentric Analgesic include Oracle Investment Management.
Will Concentric Analgesic IPO soon?
No public IPO plans have been announced for Concentric Analgesic.
How can I track Concentric Analgesic secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Concentric Analgesic's secondary market activity and sign up for updates.